-- UEG Week [https://www.ueg.eu/week/], the biggest congress of its kind in Europe, and one of the two largest in the world -- UEG Education [https://www.ueg.eu/education/], the universal source of knowledge in gastroenterology, providing online and classroom courses, a huge online library and delivering the latest GI news, fostering debate and discussion -- Activity Grants [https://www.ueg.eu/awards-grants/ueg-awards/activity-grants/], promoting and funding educational projects in the field of digestive health to advance and harmonise the training and continuing education of professionals -- UEG Journal [http://www.ueg.eu/journal/], covering translational and clinical studies from all areas of gastroenterology -- Public Affairs [http://www.ueg.eu/eu-affairs/activities/], promoting research, prevention, early diagnosis and treatment of digestive diseases, and helping develop an effective health policy for Europe -- Quality of Care [https://www.ueg.eu/guidelines/], European-based and English clinical practice guidelines, clinical standards, consensus, position papers and standard protocols in the field of digestive health, are available in the repository.
Follow UEG on Twitter [https://twitter.com/my_ueg?lang=en-gb]
Across the globe in 2018, Norgine is proud to have helped 23 million patients and generated EUR395 million in net product sales to reinvest in medicines for the future, a growth of 15% over 2017.
Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century. We understand the complexities of the European healthcare systems and have a direct presence in 14 European countries, as well as Australia and New Zealand. We also have a strong global network of partnerships in non-Norgine markets.
We are a flexible and fully integrated pharmaceutical business, with manufacturing (Hengoed, Wales and Dreux, France), third party supply networks and significant product development capabilities, in addition to our sales and marketing infrastructure. This enables us to acquire, develop and commercialise specialist and innovative products that make a real difference to the lives of patients around the world.
In 2012, Norgine established a complementary business, Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com [http://www.norgineventures.com/]
NORGINE and the sail logo are trademarks of the Norgine group of companies.
Fujifilm Europe GmbH (Duesseldorf, Germany) acts as strategic headquarter for the region and supports its group companies in Europe by formulating marketing and corporate strategies. Fujifilm entities operate in over 50 group companies and branches in Europe and employ around 4,500 people engaged in R&D, manufacturing, sales, and service. Throughout Europe they serve a range of industries including medical technology, graphic systems, electronic materials, chemicals, optical devices, recording media, and photography. Over the last decade, the company has more intensively focused on healthcare, and now looks back on over 80 years of experience in medical imaging. Today, Fujifilm provides the entire spectrum of patient care, ranging from prevention to diagnostics and therapy solutions. Today, research and development in medicine, bio-pharmaceuticals, as well as regenerative medicine are part of Fujifilm's unique portfolio.
Olympus Europa is the headquarters for the region Europe, Middle East and Africa (EMEA) of the Olympus Corporation, Tokyo. As a worldwide leading manufacturer of optical and digital precision technology, Olympus provides innovative solutions for state-of-the-art medical systems, digital cameras as well as scientific solutions in the fields of microscopy and industrial inspection. The company's award-winning products are instrumental in detecting, preventing and healing illness, driving scientific research and documenting life with artistic freedom. In the hands of its customers, Olympus' high-tech products help to make people's lives healthier, safer and more fulfilling.
1. World Health Organisation. Cancer Fact Sheet https://www.who.int/news-room/fact-sheets/detail/cancer [https://www.who.int/news-room/fact-sheets/detail/cancer] Last accessed April 2019 2. American Cancer Society. Can Colorectal Polyps and Cancer Found Early? https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-sta ging/detection.html [https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-st aging/detection.html] Last accessed April 2019 3. Bechtold ML, Mir F, Puli SR et al. Optimizing bowel preparation for colonoscopy: a guide to enhance quality of visualization. Ann Gastroenterol 2016; 29: 137 - 146 4. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014; 348: g2467 5. Baxter NN, Warren JL, Barrett MJ et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 2012; 30: 2664 - 2669
Video -- https://mma.prnewswire.com/media/1016210/UEG_Week.mp4 [https://mma.prnewswire.com/media/1016210/UEG_Week.mp4]
Logo - https://mma.prnewswire.com/media/1015679/50_Colonoscopy_UEG_Week.jpg [https://mma.prnewswire.com/media/1015679/50_Colonoscopy_UEG_Week.jpg]
CONTACT: For further information please contact: Eleni Fistikaki +44(0)1895826227 or +44 (0)7825 389477, firstname.lastname@example.org, Clara Bentham +44(0)1895 826654 or +44 (0)7734 367883, email@example.com, MatthiasGengenbach, Senior Communication Manager, +49 40 23773 firstname.lastname@example.org, To book a media interview with acolonoscopy expert please contact: Luke Paskins +44 (0)7732 499170, Findout more about UEG's work Luke Paskins on +44 (0)1444 811099 email@example.com
Web site: http://www.ueg.eu//